Skip to main content
Premium Trial:

Request an Annual Quote

Fetal Tissue Policy Changes Expected

The Biden Administration is to make changes to federal restrictions on fetal tissue research, the Washington Post reports. It adds that Health and Human Services Secretary Xavier Becerra told lawmakers Thursday that National Institutes of Health officials would be making an announcement about the policy, though without describing what the shift was.

In 2019, the Trump Administration curbed fetal tissue research in the US by ending such intramural research at NIH and by not renewing a contract with the University of California, San Francisco, a move that ended a 30-year partnership using fetal tissue for HIV research. While the new policy did not ban NIH from funding extramural fetal tissue research, it did add an extra layer of ethical review for such grant applications. ScienceInsider reported in August 2020 that the review board — which included members publicly opposed to abortion and fetal tissue research — rejected 13 of the 14 applications it had reviewed.

As the Post writes, Becerra opposes these policies and while attorney general of California was part of a group of attorneys general that called on then-HHS Secretary Alex Azar to reject ethics board's recommendations.

"We believe that we have to do the research it takes to make sure that we are incorporating innovation and getting all of those types of treatments and therapies out there to the American people," Becerra said this week during a congressional budget hearing, according to the Post.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.